Elevance Health (NYSE: ELV) director Peru lifts direct stake by 9.2%

What happened

Ramiro G. Peru bought 1,000 common shares of Elevance Health, Inc. (NYSE: ELV), adding to the director's personal investment. The purchase put about $384,000 more of Peru's money into the stock, increasing the director's exposure to the same price gains or losses other common shareholders face.

Peru bought the shares in several trades on Nov. 19 at closely grouped prices. The weighted average was $383.86 per share, and individual trades ranged from $383.62 to $383.92. The Form 4 disclosing the trades was dated Nov. 20.

The estimated cost applies to the shares bought that day, not to the value of Peru's full position. The size of that position before the purchase puts the new spending in context.

Key numbers

Metric Latest Change Source
Common shares purchased 1,000 shares SEC Form 4
Weighted average purchase price $383.86 per share SEC Form 4
Estimated purchase value About $384,000 Calculated from SEC Form 4
Direct holding after purchase 11,908 shares SEC Form 4

Read more: Elevance Health (ELV) company research

Why it matters

The purchase enlarged an existing stake. OptimistFi calculates that it increased Peru's holding by 9.2% from the 10,908 shares owned immediately before the trades. Peru held 11,908 shares directly after the purchase, so most of the resulting position was already in place.

The filing reports both the purchase and the resulting holding in common shares. The comparison therefore measures how much stock Peru added to the position, rather than how much the position's value changed with the share price.

The multiple trades all came from the same director's purchase on a single day. That distinction matters when looking for a pattern of insider buying. The trades establish that Peru added to a holding, not that other directors or officers are buying alongside Peru.

OptimistFi has argued that durable earnings and cash depend on whether Elevance Health can control benefit expense while collecting premium and fee revenue. The purchase leaves that view unchanged because the size of a director's stake gives investors a measure of personal exposure, not a measure of benefit expense.

Stock perps: every US stock that trades as a perpetual future, by leverage, live

What's next

The next quarterly report is the operating test: a lower share of revenue going to benefit expense would support OptimistFi's view, while a higher share would weaken it.

More from OptimistFi

From OptimistFi Perps

Sources

  • SEC Form 4 — Reports Peru's purchase of common stock, execution prices and direct ownership after the purchase.

Explore OptimistFi research on Elevance Health, Inc.: https://optimistfi.com/stocks/ELV

Browse Elevance Health, Inc. company coverage and explore the OptimistFi Thesis-Break Engine.

Browse every company OptimistFi covers at optimistfi.com/stocks, or read the latest evidence-first research.

Find available research on the Elevance Health, Inc. company page.

Originally published on OptimistFi, evidence-first equity research. More at optimistfi.com.